Yıl: 2020 Cilt: 26 Sayı: 2 Sayfa Aralığı: 109 - 111 Metin Dili: Türkçe DOI: 10.4274/tnd.2020.73384 İndeks Tarihi: 21-12-2020

COVID-19 ve Nöroloji

Öz:
Nörolojik hastalıklar bütün dünyada en fazla sağlık yükü oluşturan hastalık gruplarındandır. Çoğu kronik ve iyi takip edilmesi gereken risk faktörlerine bağlı olannörolojik hastalık alanına yeni koronavirüs hastalığı-19 (COVID-19) pandemisi ile yeni ve ağır bir yük daha eklenmiştir. Nörolojik sisteme etkileri giderek dahafazla yayımlanmakta olan Severe Acute Respiratory syndrome-Coronavirus-2’nin nörolojik tutulum yapma sıklığı ve mekanizmaları multidisipliner ekip içindenörologların da yer alması ile daha iyi anlaşılabilecektir. Diğer bir önemli durum ise, COVID-19 nedeniyle yapılan olağanüstü düzenlemelerin kronik gidişli, sıkve düzenli kontrol gerektiren, akut müdahale gerektiren hastaların izlem ve tedavilerini aksatabilme durumudur. Nöroloji uzmanlarının bu dengeleri koruyaraksahadaki sorumluluklarını yerine getirecek düzenlemeler yapılması hayati önemdedir.
Anahtar Kelime:

COVID-19 and Neurology

Öz:
Neurological diseases are the most common and important health burden over the world. Coronavirus disease-19 (COVID-19) pandemic is a new and important burden for the neurological area. Information related to the neurological involvement of Severe Acute Respiratory syndrome-Coronavirus-2 infection has been increased during the last several months. Frequency and mechanisms of neurological involvement of the disease may be explained more efficiently by neurologists who are included within the multidisciplinary COVID-19 teams. Other very important point is possibility of failure of follow up and treatment of chronic neurological disorders which needed frequent and regular control and also quick action for the acute treatment. The regulations are extremely important for the neurologists to perform their responsibilities with considering all these requirements.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Erişime Açık
  • 1. GBD 2016 Neurology Collaborators. Global, regional, and national burden of stroke, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 2019;18:439-458.
  • 2. Mao L, Wang M, Chen S, et al. Neurological manifestations of hospitalized patients with COVID-19 in Wuhan, China: a retrospective case series study. SSRN Journal 2020 medRxiv. Epubaheadofprint 25 February 2020. DOI: 10.1101/2020.02.22.20026500.
  • 3. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497-506.
  • 4. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020;395:507-513.
  • 5. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet 2020;395:497-506.
  • 6. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronanavirus-infected pneumonia inWuhan, China. JAMA 2020.
  • 7. Baig AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms. ACS Chem Neurosci 2020;11:995-998.
  • 8. Shi S, Qin M, Shen B, et al. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiol 2020.
  • 9. Giacomelli A, Pezzati L, Conti F, et al. Self-reported olfactory and taste disorders in SARS-CoV-2 patients: a cross-sectional study. Clin Infect Dis. 2020.
  • 10. Bohmwald K, Gálvez NMS, Ríos M, Kalergis A M. Neurologic Alterations Due to Respiratory Virus Infections. Frontiers in Cellular Neuroscience 2018;12:386.
  • 11. Mao L, Wang M, Chen S, et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol 2020.
  • 12. Duffin J. Functional organization of respiratory neurones:a brief review of current questions and speculations. Exp Physiol 2004;89:517-529.
  • 13. Poyiadji N, Shahin G, Noujaim D, Stone M, Patel S, Griffith B. COVID-19- associated Acute Hemorrhagic Necrotizing Encephalopathy: CT and MRI Features. Radiology 2020:201187.
  • 14. Baig AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms. ACS Chem Neurosci 2020;11: 995-998.
  • 15. Netland J, Meyerholz DK, Moore S, Cassell M, Perlman S. Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence absence of encephalitis in mice transgenic for human ACE2. J Virol 2008;82:7264-7275.
  • 16. Poyiadji N, Shahin G, Noujaim D, Stone M, Patel S, Griffith B. COVID-19- associated Acute Hemorrhagic Necrotizing Encephalopathy: CT and MRI Features. Radiology 2020:201187.
  • 17. Filatov A, Sharma P, Hindi F, et al. (March 21, 2020) Neurological Complications of Coronavirus Disease (COVID-19): Encephalopathy. Cureus 2020;12:7352.
  • 18. Onder G, Rezza G, Brusaferro S. Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. JAMA 2020.
  • 19. Federico, A. Brain Awareness Week, CoVID-19 infection and Neurological Sciences. Neurol Sci 2020.
  • 20. https://wfneurology.org/covid-19-and-world-neurology (Erişim: Mart 2020)
  • 21. https://www.ean.org/Recommendations-Guidelines.4326.0.html (Erişim: Mart 2020)
  • 22. https://www.aan.com/tools-and-resources/covid-19-neurology-resourcecenter/ (Erişim: Mart 2020)
  • 23. https://www.noroloji.org.tr/menu/158/covid-19-bilgi (Erişim: Mart 2020)
  • 24. TC-Sağlık-Bakanlığı. COVID-19-SARS-CoV-2 enfeksiyonu rehberi (Bilim Kurulu Çalışması). https://covid19bilgisaglikgovtr/depo/rehberler/ COVID-19_Rehberipdf 2-4-2020
APA Ozturk S (2020). COVID-19 ve Nöroloji. , 109 - 111. 10.4274/tnd.2020.73384
Chicago Ozturk Serefnur COVID-19 ve Nöroloji. (2020): 109 - 111. 10.4274/tnd.2020.73384
MLA Ozturk Serefnur COVID-19 ve Nöroloji. , 2020, ss.109 - 111. 10.4274/tnd.2020.73384
AMA Ozturk S COVID-19 ve Nöroloji. . 2020; 109 - 111. 10.4274/tnd.2020.73384
Vancouver Ozturk S COVID-19 ve Nöroloji. . 2020; 109 - 111. 10.4274/tnd.2020.73384
IEEE Ozturk S "COVID-19 ve Nöroloji." , ss.109 - 111, 2020. 10.4274/tnd.2020.73384
ISNAD Ozturk, Serefnur. "COVID-19 ve Nöroloji". (2020), 109-111. https://doi.org/10.4274/tnd.2020.73384
APA Ozturk S (2020). COVID-19 ve Nöroloji. Türk Nöroloji Dergisi, 26(2), 109 - 111. 10.4274/tnd.2020.73384
Chicago Ozturk Serefnur COVID-19 ve Nöroloji. Türk Nöroloji Dergisi 26, no.2 (2020): 109 - 111. 10.4274/tnd.2020.73384
MLA Ozturk Serefnur COVID-19 ve Nöroloji. Türk Nöroloji Dergisi, vol.26, no.2, 2020, ss.109 - 111. 10.4274/tnd.2020.73384
AMA Ozturk S COVID-19 ve Nöroloji. Türk Nöroloji Dergisi. 2020; 26(2): 109 - 111. 10.4274/tnd.2020.73384
Vancouver Ozturk S COVID-19 ve Nöroloji. Türk Nöroloji Dergisi. 2020; 26(2): 109 - 111. 10.4274/tnd.2020.73384
IEEE Ozturk S "COVID-19 ve Nöroloji." Türk Nöroloji Dergisi, 26, ss.109 - 111, 2020. 10.4274/tnd.2020.73384
ISNAD Ozturk, Serefnur. "COVID-19 ve Nöroloji". Türk Nöroloji Dergisi 26/2 (2020), 109-111. https://doi.org/10.4274/tnd.2020.73384